We currently offering clinical trials for a variety of common oncologic diseases, including breast, lung and colon cancer. We are involved in trials that involve targeted therapies or monoclonal antibodies. These treatments, which are less toxic than chemotherapy, interfere with cell communication that is part of the cancer process.
Please access our Human Research Protocols for more information.
For more information about research and clinical trials at Rush North Shore, call Lisbeth Lynn, Human Subjects Research Administrator/Research Education Coordinator at 847.933.6587.